Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Farge

Showing results (91-100 of 192) with videos related to

Pageof 20
Sort By:
Heliyon|January 26, 2017
Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolismJavier Trujillo-Santos, Francisco Martín Martos, Carme Font, et al.
International Angiology : a Journal of the International Union of Angiology|May 22, 2019
Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE DatabaseHarry E Fuentes, Alfonso J Tafur, Joseph A Caprini, et al.
Research and Practice in Thrombosis and Haemostasis|June 6, 2022
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT studyJavier Trujillo-Santos, Dominique Farge-Bancel, José María Pedrajas, et al.
Cancer Medicine|October 6, 2017
Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS studyPhilippe Debourdeau, Marc Espié, Sylvie Chevret, et al.
British Journal of Haematology|November 20, 2002
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II studyDominique Farge, Jean Pierre Marolleau, Sarah Zohar, et al.
The Journal of Rheumatology|June 3, 2009
Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie)Kiet Phong Tiev, Elisabeth Diot, Pierre Clerson, et al.
Bone Marrow Transplantation|October 17, 2024
Autologous hematopoietic stem cell transplantation in a patient with multi-refractory stiff person syndromeTamim Alsuliman, Dimitri Psimaras, Nicolas Stocker, et al.
Rheumatology (Oxford, England)|May 14, 2024
Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis-a two-step approachShiri Keret, Boris Chutko, Idit Dobrecky-Mery, et al.
Journal of Thrombosis and Thrombolysis|July 23, 2021
Effectiveness of a multidisciplinary care program for the management of venous thromboembolism in cancer patients: a pilot studyIlham Benzidia, Benjamin Crichi, Claire Montlahuc, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 23, 2020
Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE RegistryCarmine Siniscalchi, José M Suriñach, Adriana Visonà, et al.
Pageof 20

Showing results (91-100 of 192) with videos related to

Sort By:
Pageof 20
Heliyon|January 26, 2017
Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolismJavier Trujillo-Santos, Francisco Martín Martos, Carme Font, et al.
International Angiology : a Journal of the International Union of Angiology|May 22, 2019
Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE DatabaseHarry E Fuentes, Alfonso J Tafur, Joseph A Caprini, et al.
Research and Practice in Thrombosis and Haemostasis|June 6, 2022
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT studyJavier Trujillo-Santos, Dominique Farge-Bancel, José María Pedrajas, et al.
Cancer Medicine|October 6, 2017
Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS studyPhilippe Debourdeau, Marc Espié, Sylvie Chevret, et al.
British Journal of Haematology|November 20, 2002
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II studyDominique Farge, Jean Pierre Marolleau, Sarah Zohar, et al.
The Journal of Rheumatology|June 3, 2009
Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie)Kiet Phong Tiev, Elisabeth Diot, Pierre Clerson, et al.
Bone Marrow Transplantation|October 17, 2024
Autologous hematopoietic stem cell transplantation in a patient with multi-refractory stiff person syndromeTamim Alsuliman, Dimitri Psimaras, Nicolas Stocker, et al.
Rheumatology (Oxford, England)|May 14, 2024
Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis-a two-step approachShiri Keret, Boris Chutko, Idit Dobrecky-Mery, et al.
Journal of Thrombosis and Thrombolysis|July 23, 2021
Effectiveness of a multidisciplinary care program for the management of venous thromboembolism in cancer patients: a pilot studyIlham Benzidia, Benjamin Crichi, Claire Montlahuc, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 23, 2020
Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE RegistryCarmine Siniscalchi, José M Suriñach, Adriana Visonà, et al.
Pageof 20